Acquired by Orthofix Medical Inc. in Jan 2023
Company logo

SPNE - SeaSpine Holdings Corporation

NASDAQ -> Healthcare -> Medical Devices
Carlsbad, United States
Type: Equity

SPNE price evolution
SPNE
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Current assets
Cash $46.76 $66.08 $81.44 $83.11
Short term investments
Net receivables $43.54 $34.44 $36.07 $36.23
Inventory $83.99 $85.91 $76.53 $72.3
Total current assets $174.87 $190 $198.04 $195.96
Long term investments
Property, plant & equipment $72.71 $71.45 $56.94 $53.84
Goodwill & intangible assets $121.13 $122.97 $124.81 $126.65
Total noncurrent assets $199.26 $195.57 $182.37 $181.3
Total investments
Total assets $374.12 $385.57 $380.41 $377.27
Current liabilities
Accounts payable $17.78 $19.22 $16.48 $20.3
Deferred revenue $2.14 $2.26 $2.37 $1.54
Short long term debt $2.41 $2.38 $27.23 $2.23
Total current liabilities $55.05 $54.44 $72.95 $52.98
Long term debt $40.94 $40.53 $5.4 $5.87
Total noncurrent liabilities $44.62 $44.3 $10.64 $11.92
Total debt $43.35 $42.91 $32.63 $8.1
Total liabilities $99.67 $98.74 $83.59 $64.9
Shareholders' equity
Retained earnings -$319.65 -$304.15 -$290.21 -$273.6
Other shareholder equity $0.43 $0.93 $1.4 $1.57
Total shareholder equity $274.46 $286.83 $296.82 $312.36
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Current assets
Cash $83.11 $76.81 $20.2 $24.23
Short term investments $29.8
Net receivables $36.23 $26.15 $24.9 $20.34
Inventory $72.3 $54.04 $47.16 $42.74
Total current assets $195.96 $160.89 $96.16 $120.06
Long term investments
Property, plant & equipment $53.84 $39.08 $25.75 $22.62
Goodwill & intangible assets $126.65 $13.88 $19.17 $28.71
Total noncurrent assets $181.3 $53.51 $45.56 $52.28
Total investments $29.8
Total assets $377.27 $214.4 $141.72 $172.34
Current liabilities
Accounts payable $20.3 $5.01 $7.45 $9.21
Deferred revenue $1.54
Short long term debt $2.23 $3.26
Total current liabilities $52.98 $30.73 $30.48 $26.55
Long term debt $5.87 $11.86
Total noncurrent liabilities $11.92 $11.96 $1.48 $3.71
Total debt $8.1 $15.12
Total liabilities $64.9 $42.68 $31.96 $30.26
Shareholders' equity
Retained earnings -$273.6 -$219.26 -$176.08 -$136.8
Other shareholder equity $1.57 $2.12 $1.43 $1.6
Total shareholder equity $312.36 $171.72 $109.76 $142.09
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Revenue
Total revenue $67.15 $56.32 $50.69 $55.59
Cost of revenue $26.64 $19.13 $20.38 $25.73
Gross Profit $40.51 $37.19 $30.32 $29.86
Operating activities
Research & development $6.6 $5.65 $5.85 $6.39
Selling, general & administrative $47.75 $45.22 $40.45 $41.77
Total operating expenses $55.2 $51.73 $47.15 $48.9
Operating income -$14.69 -$14.54 -$16.83 -$19.04
Income from continuing operations
EBIT -$15.11 -$15.09 -$16.83 -$19.2
Income tax expense $0.39 -$1.15 -$0.23 -$0.41
Interest expense
Net income
Net income -$15.5 -$13.95 -$16.6 -$18.79
Income (for common shares) -$15.5 -$13.95 -$16.6 -$18.79
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Revenue
Total revenue $191.45 $154.34 $159.08 $143.44
Cost of revenue $76.86 $56.84 $57.98 $55.97
Gross Profit $114.59 $97.5 $101.1 $87.47
Operating activities
Research & development $22.01 $16.26 $15.13 $12.06
Selling, general & administrative $150.24 $120.18 $117.04 $105.39
Total operating expenses $175.56 $140.93 $140.33 $120.61
Operating income -$60.98 -$43.43 -$39.22 -$33.14
Income from continuing operations
EBIT -$55.45 -$42.96 -$38.92 -$33.4
Income tax expense -$1.1 $0.22 $0.36 $0.13
Interest expense
Net income
Net income -$54.35 -$43.18 -$39.28 -$33.52
Income (for common shares) -$54.35 -$43.18 -$39.28 -$33.52
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Net income -$15.5 -$13.95 -$16.6 -$18.79
Operating activities
Depreciation $4.34 $4.29 $4.2 $3.65
Business acquisitions & disposals $0.33
Stock-based compensation $3.65 $3.7 $2.82 $3.06
Total cash flows from operations -$11.07 -$8.13 -$14.99 -$11.13
Investing activities
Capital expenditures -$7.94 -$7.74 -$10.06 -$9.35
Investments
Total cash flows from investing -$7.94 -$7.74 -$10.06 -$8.97
Financing activities
Dividends paid
Sale and purchase of stock -$0.03 $0.72 -$1.58 $0.87
Net borrowings $25
Total cash flows from financing -$0.04 $0.71 $23.4 $0.86
Effect of exchange rate -$0.26 -$0.2 -$0.02 -$0.08
Change in cash and equivalents -$19.32 -$15.36 -$1.67 -$19.33
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Net income -$54.35 -$43.18 -$39.28 -$33.52
Operating activities
Depreciation $13.93 $10.72 $10.35 $10.7
Business acquisitions & disposals -$28
Stock-based compensation $11.86 $10.36 $7.81 $5.8
Total cash flows from operations -$33.51 -$24.6 -$20.28 -$12.56
Investing activities
Capital expenditures -$27.4 -$17.04 -$12.83 -$8.35
Investments -$0.01 $30 -$29.76
Total cash flows from investing -$55.36 -$17.04 $17.17 -$38.1
Financing activities
Dividends paid
Sale and purchase of stock $95.64 $92.09 -$0.69 $64.5
Net borrowings -$0.04 $6.17 -$0.17
Total cash flows from financing $95.55 $98.14 -$0.83 $64.2
Effect of exchange rate -$0.38 $0.12 -$0.09 -$0.09
Change in cash and equivalents $6.29 $56.61 -$4.03 $13.45
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding 37.20M
Revenue $229.75M
EBITDA -$49.74M
EBIT -$66.23M
Net Income -$64.84M
Revenue Q/Q 44.57%
Revenue Y/Y 26.03%
P/E ratio 0.00
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 0.00
Book/Share 7.37
Cash/Share 1.26
EPS -$1.74
ROA -17.09%
ROE -22.16%
Debt/Equity 0.21
Net debt/EBITDA -1.06
Current ratio 3.18
Quick ratio 1.65